• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Chinese CRO Company Report - ShangPharma Product Image

Chinese CRO Company Report - ShangPharma

  • Published: November 2012
  • Region: Global, Asia, China
  • 51 Pages
  • JZMed Inc

The booming Chinese pharma outsourcing service industry has fostered the emergence of a large number of professional service providers in China in the past decade. A number of them have gained sufficient capabilities and become as competent as those top tier players in the same service sector of the global pharma outsourcing industry.

To help global pharma outsourcing companies and professional service providers as well as venture capital investors better understand the current development state of this Chinese industry, we have successfully identified the current top five players of the Chinese pharma outsourcing service industry, and published them in this series of Company Reports. The selection is based on the results of the in-depth evaluation against each and every Chinese/China-based service provider out of a vast pool of service companies in JZMed’s database.

In this report a complete description and an in-depth analysis about ShangPharma is presented. The report is a valuable reference to global pharmaceutical, biotechnology, financial investment and outsourcing service companies that are interested in gaining better understanding about the current development READ MORE >

Scope of the Report

Executive Summary

Introduction

Part One - Current State of Chinese Pharma Outsourcing service Industry
1.1 Current structural composition and service capabilities of Chinese pharma outsourcing service industry
1.2 Current customer distributions of Chinese pharma outsourcing service providers
1.3 Current FTE rate and cost saving for outsourcing in China and comparison with other countries
1.4 Current market size and past growth history of Chinese pharma outsourcing service industry
1.5 Where China currently stands in global pharma outsourcing service market

Part Two - Analysis of Current State of ShangPharma
2.1 Growth history of ShangPharma
2.2 Services currently offered by ShangPharma
2.3 Analysis of ShangPharma’s current service revenue, its compositions and growth history
2.4 Where ShangPharma currently stands in entire Chinese pharma outsourcing service market

Part Three - Main Collaborations of ShangPharma with Global Pharma and Biopharma Companies

Part Four - Analysis of Future Growth Potentials of Chinese Pharma Outsourcing Service Market
4.1 Analysis of future growth drivers and resistors of Chinese pharma outsourcing service market
4.1.1 Future growth drivers
1. Attraction of Chinese pharmaceutical market to global drug companies
2. China’s natural advantages
3. Increasing outsourcing demands by major pharma companies
4. Increasing outsourcing demands by global R&D-focused biotech companies
5. Increasing outsourcing demands by domestic drug companies
4.1.2 Growth hurdles facing Chinese pharma outsourcing service industry
1. Fast rising labor cost
2. Still-weak service capabilities of majority Chinese CROs/CMOs
3. Growth limit of outsourcing service demand for small molecule drug
discovery in China
4.2 Market growth forecast (to 2017) of Chinese pharma outsourcing service industry

Part Five - Analysis of Future Growth Potentials of ShangPharma
5.1 Analysis of ShangPharma’s current service strengths
5.2 ShangPharma’s new development focuses aiming future growth
5.3 Analysis of growth weakness in ShangPharma’s service revenue
5.4 Analysis of ShangPharma’s competitors in both domestic and international markets
5.4.1 Domestic competitors
1. Comparison with WuXi PharmaTech
2. Other domestic competitors
5.4.2 International competitors
5.5 Future revenue growth predictions (to 2017) for ShangPharma

Company Profile of ShangPharma

Appendix

Appendix I. Research Methodology

Appendix II. About JZMed, Inc.

List of Tables

Table 1. Top Five Chinese pharma outsourcing service providers
Table 2. Comparison of labor costs (FTE rates) in various locations of the world
Table 3. Market values and growth rates of Chinese pharma outsourcing service industry in past five years
Table 4. Revenue growth history of ShangPharma in past four years
Table 5. 2010 Quarterly revenue performances of ShangPharma
Table 6. 2011 Quarterly revenue performances of ShangPharma
Table 7. 2012 Quarterly revenue performances of ShangPharma
Table 8. Combined 2011 quarterly service revenues of ShangPharma from top 10 customers
Table 9. Combined 2012 quarterly service revenues of ShangPharma from top 10 customers
Table 10. 2011 Quarterly service revenue growths of ShangPharma from domestic customers
Table 11. Development history, current market size and future growth forecast of the Western-style medicines in Chinese pharmaceutical market
Table 12. China’s key advantages attracting multinational companies to outsource
Table 13. Growth drivers of Chinese pharma outsourcing service market
Table 14. Small molecule drug discovery outsourcing in China approaching mature
Table 15. Forecasted future growth of Chinese pharma outsourcing service market
Table 16. Forecasted future growths of global professional CRO, CMO and total pharma outsourcing service markets
Table 17. ShangPharma’s top domestic competitors
Table 18. ShangPharma’s top international competitors
Table 19. Revenue growth forecast to 2017 for ShangPharma

List of Figures

Figure 1. Current customer distributions of Chinese CROs/CMOs
Figure 2. Growth trend of Chinese pharma outsourcing service market in past five years
Figure 3. An overview of current state of Chinese pharma outsourcing service industry
Figure 4. Current market distributions of each service sector in global pharma outsourcing service industry
Figure 5. Revenue growth trends of ShangPharma in past four years
Figure 6. Changes of ranking of Chinese pharmaceutical market in global market in past decade
Figure 7. Forecasted future growth trends of Chinese pharma outsourcing service market
Figure 8. Forecasted future growth trends of global pharma outsourcing service market
Figure 9. Forecasted future revenue growth trends of ShangPharma
Figure 10. ShangPharma’s staff growth forecast

List of Case Studies

Case Study 1. Pfizer looking for partnership opportunities with Asian organizations
Case Study 2. ShangPharma attracting biotech companies for mAb drug discovery and development
Case Study 3. Comparisons of key differences between WuXi PharmaTech and ShangPharma

Note: Product cover images may vary from those shown

RELATED PRODUCTS